The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Outgrowth Endothelial Cells: Characterization and Their Potential for Reversing Ischemic Retinopathy
Abstract
PURPOSE: Endothelial progenitor cells (EPCs) have potential for promoting vascular repair and revascularization of ischemic retina. However, the highly heterogeneous nature of these cells causes confusion when assessing their biological functions. The purpose of this study was to provide a comprehensive comparison between the two main EPC subtypes, early EPCs (eEPCs) and outgrowth endothelial cells (OECs), and to establish the potential of OECs as a novel cell therapy for ischemic retinopathy. METHODS: Two types of human blood-derived EPCs were isolated and compared using immunophenotyping and multiple in vitro functional assays to assess interaction with retinal capillary endothelial cells and angiogenic activity. OECs were delivered intravitreally in a mouse model of ischemic retinopathy, and flat mounted retinas were examined using confocal microscopy. RESULTS: These data indicate that eEPCs are hematopoietic cells with minimal proliferative capacity that lack tube-forming capacity. By contrast, OECs are committed to an endothelial lineage and have significant proliferative and de novo tubulogenic potential. Furthermore, only OECs are able to closely interact with endothelial cells through adherens and tight junctions and to integrate into retinal vascular networks in vitro. The authors subsequently chose OECs to test a novel cell therapy approach for ischemic retinopathy. Using a murine model of retinal ischemia, they demonstrated that OECs directly incorporate into the resident vasculature, significantly decreasing avascular areas, concomitantly increasing normovascular areas, and preventing pathologic preretinal neovascularization. CONCLUSIONS: As a distinct EPC population, OECs have potential as therapeutic cells to vascularize the ischemic retina.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A comparison of the tube forming potentials of early and late endothelial progenitor cells
Mukai, N., Akahori, T., Komaki, M., Li, Q., Kanayasu-Toyoda, T., Ishii-Watabe, A., Kobayashi, A., Yamaguchi, T., Abe, M., Amagasa, T., et al. (2008) · Experimental Cell Research · doi:10.1016/j.yexcr.2007.11.016 · Cited by 157
Van Craenenbroeck, E. M. F., Conraads, V. M. A., Van Bockstaele, D. R., Haine, S. E., Vermeulen, K., Van Tendeloo, V. F., Vrints, C. J., & Hoymans, V. Y. (2008) · Journal of Immunological Methods · doi:10.1016/j.jim.2007.12.006 · Cited by 77
Cited by
The progress in understanding and treatment of diabetic retinopathy
Stitt, A. W., Curtis, T. M., Chen, M., Medina, R. J., McKay, G. J., Jenkins, A., Gardiner, T. A., Lyons, T. J., Hammes, H.-P., Simó, R., et al. (2016) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2015.08.001 · Cited by 1,164
Self-citationCurrent understanding of the molecular and cellular pathology of diabetic retinopathy
Antonetti, D. A., Silva, P. S., & Stitt, A. W. (2021) · Nature Reviews Endocrinology · doi:10.1038/s41574-020-00451-4 · Cited by 645
Self-citationGuduric-Fuchs, J., O’Connor, A., Camp, B., O'Neill, C. L., Medina, R. J., & Simpson, D. A. (2012) · BMC Genomics · doi:10.1186/1471-2164-13-357 · Cited by 556
Self-citationO'Neill, C. L., McLoughlin, K. J., Chambers, S. E. J., Guduric-Fuchs, J., Stitt, A. W., & Medina, R. J. (2018) · Frontiers in Medicine · doi:10.3389/fmed.2018.00273 · Cited by 43
Self-citationReskiawan A. Kadir, R., Alwjwaj, M., Ahmad Othman, O., Rakkar, K., Sprigg, N., Bath, P. M., & Bayraktutan, U. (2022) · Brain Research · doi:10.1016/j.brainres.2022.147925 · Cited by 22
Kadir, R. R. A., Alwjwaj, M., & Bayraktutan, U. (2022) · Metabolic Brain Disease · doi:10.1007/s11011-022-01041-1 · Cited by 17
“We and others have previously shown that OECs isolated in this fashion also express specific markers for immaturity (CD133), stemness (CD34), and endothelial maturity (CD31), but not for hematopoietic cells (CD45) (Medina et al. 2010; Abdulkadir et al. 2020).”
Background
Metadata
- Authors
- Medina, R. J., O'Neill, C. L., Humphreys, M. W., Gardiner, T. A., & Stitt, A. W.
- Venue
- Investigative Opthalmology & Visual Science
- Published
- 2010-11-01
- Volume
- 51
- Issue
- 11
- Pages
- 5906
- ISSN
- 0146-0404 (ISSN-L)
- 1552-5783
- OpenAlex
- W2090010220
- Cited by
- 172
- References
- 2
- FWCI
- 3.78
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.